Skip to main content
Erschienen in: Surgical Endoscopy 12/2018

04.06.2018

Cost-effectiveness analysis of laparoscopic versus open surgery in colon cancer

verfasst von: Javier Mar, Ane Anton-Ladislao, Oliver Ibarrondo, Arantzazu Arrospide, Santiago Lázaro, Nerea Gonzalez, Marisa Bare, Daniel Callejo, Maximino Redondo, José M. Quintana, the REDISSEC-CARESS/CCR group

Erschienen in: Surgical Endoscopy | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Few economic evaluations have assessed laparoscopy for colon cancer. This study aimed to compare the cost-effectiveness of laparoscopic and open surgery for the treatment of colon cancer.

Method

A cost-effectiveness analysis was performed comparing two groups of patients treated according to standard clinical practice (REDISSEC-CARESS/CCR cohort) by laparoscopic or open surgery. Data were collected from health records on clinical characteristics and resource use over 2 years after surgery. To calculate the incremental cost-effectiveness ratio, costs and quality-adjusted life years (QALYs) were obtained for each patient. Clinical heterogeneity was addressed using propensity score and joint multivariable analysis (seemingly unrelated regression) that included interactions between TNM stage, age, and surgical procedure to perform subgroup analysis.

Results

The sample was composed of 1591 patients, 963 who underwent laparoscopy and 628 open surgery. Using propensity score and regression analysis, we found that laparoscopy was associated with more QALYs and less resource use than open surgery (0.0163 QALYs, 95% CI 0.0114–0.0212; and − €3461, 95% CI − 3337 to − 3586). Costs were lower for laparoscopy in all subgroups. In the subgroups younger than 80 years old, utility was higher in patients who underwent laparoscopy. Nevertheless, open surgery had better outcomes in older patients in stages I–II (0.0618 QALYs) and IV (0.5090 QALYs).

Conclusion

Overall, laparoscopy appears to be dominant, resulting in more QALYs and lower costs. Nevertheless, while laparoscopy required fewer resources in all subgroups, outcomes may be negatively affected in elderly patients, representing an opportunity for shared decision making between surgeons and patients.
ClinicalTrials.gov Identifier: NCT02488161
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Center MM, Jemal A, Smith RA, Ward E (2009) Worldwide variations in colorectal cancer. CA Cancer J Clin 59:366–378CrossRef Center MM, Jemal A, Smith RA, Ward E (2009) Worldwide variations in colorectal cancer. CA Cancer J Clin 59:366–378CrossRef
2.
Zurück zum Zitat Gellad ZF, Provenzale D (2010) Colorectal cancer: national and international perspective on the burden of disease and public health impact. Gastroenterology 138:2177–2190CrossRef Gellad ZF, Provenzale D (2010) Colorectal cancer: national and international perspective on the burden of disease and public health impact. Gastroenterology 138:2177–2190CrossRef
3.
Zurück zum Zitat Murray A, Lourenco T, de Verteuil R, Hernandez R, Fraser C, McKinley A, Krukowski Z, Vale L, Grant A (2006) Clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer: systematic reviews and economic evaluation. Health Technol Assess 10:1–141CrossRef Murray A, Lourenco T, de Verteuil R, Hernandez R, Fraser C, McKinley A, Krukowski Z, Vale L, Grant A (2006) Clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer: systematic reviews and economic evaluation. Health Technol Assess 10:1–141CrossRef
4.
Zurück zum Zitat Jensen CC, Prasad LM, Abcarian H (2012) Cost-effectiveness of laparoscopic vs open resection for colon and rectal cancer. Dis Colon Rectum 55:1017–1023CrossRef Jensen CC, Prasad LM, Abcarian H (2012) Cost-effectiveness of laparoscopic vs open resection for colon and rectal cancer. Dis Colon Rectum 55:1017–1023CrossRef
5.
Zurück zum Zitat Braga M, Frasson M, Zuliani W, Vignali A, Pecorelli N, Di Carlo V (2010) Randomized clinical trial of laparoscopic versus open left colonic resection. Br J Surg 97:1180–1186CrossRef Braga M, Frasson M, Zuliani W, Vignali A, Pecorelli N, Di Carlo V (2010) Randomized clinical trial of laparoscopic versus open left colonic resection. Br J Surg 97:1180–1186CrossRef
7.
Zurück zum Zitat Veldkamp R, Kuhry E, Hop WC, Jeekel J, Kazemier G, Bonjer HJ, Haglind E, Påhlman L, Cuesta MA, Msika S, Morino M, Lacy AM, COlon cancer Laparoscopic or Open Resection Study Group (COLOR) (2005) Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomized trial. Lancet Oncol 6:477–484CrossRef Veldkamp R, Kuhry E, Hop WC, Jeekel J, Kazemier G, Bonjer HJ, Haglind E, Påhlman L, Cuesta MA, Msika S, Morino M, Lacy AM, COlon cancer Laparoscopic or Open Resection Study Group (COLOR) (2005) Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomized trial. Lancet Oncol 6:477–484CrossRef
8.
Zurück zum Zitat Leung KL, Kwok SP, Lam SC, Lee JF, Yiu RY, Ng SS, Lai PB, Lau WY (2004) Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial. Lancet 363:1187–1192CrossRef Leung KL, Kwok SP, Lam SC, Lee JF, Yiu RY, Ng SS, Lai PB, Lau WY (2004) Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial. Lancet 363:1187–1192CrossRef
9.
Zurück zum Zitat Delaney CP, Kiran RP, Senagore AJ, Brady K, Fazio VW (2003) Case-matched comparison of clinical and financial outcome after laparoscopic or open colorectal surgery. Ann Surg 238:67–72PubMedPubMedCentral Delaney CP, Kiran RP, Senagore AJ, Brady K, Fazio VW (2003) Case-matched comparison of clinical and financial outcome after laparoscopic or open colorectal surgery. Ann Surg 238:67–72PubMedPubMedCentral
10.
Zurück zum Zitat Latimer NR (2013) Survival analysis for economic evaluations alongside clinical trials–extrapolation with patient-level data: inconsistencies, limitations, and a practical guide. Med Decis Mak 33:743–754CrossRef Latimer NR (2013) Survival analysis for economic evaluations alongside clinical trials–extrapolation with patient-level data: inconsistencies, limitations, and a practical guide. Med Decis Mak 33:743–754CrossRef
11.
Zurück zum Zitat Tappenden P, Chilcott J, Ward S, Eggington S, Hind D, Hummel S (2006) Methodological issues in the economic analysis of cancer treatments. Eur J Cancer 42:2867–2875CrossRef Tappenden P, Chilcott J, Ward S, Eggington S, Hind D, Hummel S (2006) Methodological issues in the economic analysis of cancer treatments. Eur J Cancer 42:2867–2875CrossRef
12.
Zurück zum Zitat Ara R, Basarir H, Keetharuth AD, Barbieri M, Weatherly HL, Sculpher MJ, Ahmed H, Brown S (2014) Are policy decisions on surgical procedures informed by robust economic evidence? A systematic review. Int J Technol Assess Health Care 30:381–393CrossRef Ara R, Basarir H, Keetharuth AD, Barbieri M, Weatherly HL, Sculpher MJ, Ahmed H, Brown S (2014) Are policy decisions on surgical procedures informed by robust economic evidence? A systematic review. Int J Technol Assess Health Care 30:381–393CrossRef
13.
Zurück zum Zitat Park JS, Kang SB, Kim SW, Cheon GN (2007) Economics and the laparoscopic surgery learning curve: comparison with open surgery for rectosigmoid cancer. World J Surg 31:1827–1834CrossRef Park JS, Kang SB, Kim SW, Cheon GN (2007) Economics and the laparoscopic surgery learning curve: comparison with open surgery for rectosigmoid cancer. World J Surg 31:1827–1834CrossRef
14.
Zurück zum Zitat Quintana JM, Gonzalez N, Anton-Ladislao A, Redondo M, Bare M, Fernandez de Larrea N, Briones E, Escobar A, Sarasqueta C, Garcia-Gutierrez S, Aguirre U, REDISSEC-CARESS/CCR group (2016) Colorectal cancer health services research study protocol: the CCR-CARESS observational prospective cohort project. BMC Cancer 16:435CrossRef Quintana JM, Gonzalez N, Anton-Ladislao A, Redondo M, Bare M, Fernandez de Larrea N, Briones E, Escobar A, Sarasqueta C, Garcia-Gutierrez S, Aguirre U, REDISSEC-CARESS/CCR group (2016) Colorectal cancer health services research study protocol: the CCR-CARESS observational prospective cohort project. BMC Cancer 16:435CrossRef
15.
Zurück zum Zitat Concato J, Shah N, Horwitz RI (2000) Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342:1887–1892CrossRef Concato J, Shah N, Horwitz RI (2000) Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342:1887–1892CrossRef
16.
Zurück zum Zitat Benson K, Hartz AJ (2000) A comparison of observational studies and randomized, controlled trials. N Engl J Med 342:1878–1886CrossRef Benson K, Hartz AJ (2000) A comparison of observational studies and randomized, controlled trials. N Engl J Med 342:1878–1886CrossRef
17.
Zurück zum Zitat Silverman SL (2009) From randomized controlled trials to observational studies. Am J Med 122:114–120CrossRef Silverman SL (2009) From randomized controlled trials to observational studies. Am J Med 122:114–120CrossRef
18.
Zurück zum Zitat Gatta G, Trama A, Capocaccia R (2013) Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization. J Natl Cancer Inst Monogr 46:79–87CrossRef Gatta G, Trama A, Capocaccia R (2013) Variations in cancer survival and patterns of care across Europe: roles of wealth and health-care organization. J Natl Cancer Inst Monogr 46:79–87CrossRef
19.
Zurück zum Zitat Garrison LP, Neumann PJ, Erickson P, Marshall D, Mullins CD (2007) Using real-world data for coverage and payment decisions: the ISPOR real-world data task force report. Value in Health 10:326–335CrossRef Garrison LP, Neumann PJ, Erickson P, Marshall D, Mullins CD (2007) Using real-world data for coverage and payment decisions: the ISPOR real-world data task force report. Value in Health 10:326–335CrossRef
20.
Zurück zum Zitat Drummond MF, Sculpher MJ, Torrance GW (2005) Methods for the economic evaluation of health care programmes. Oxford University Press, New York Drummond MF, Sculpher MJ, Torrance GW (2005) Methods for the economic evaluation of health care programmes. Oxford University Press, New York
21.
Zurück zum Zitat Gold M, Siegel JE, Russell LB, Weinstein MC (1996) Cost-effectiveness in health and medicine. Oxford University Press, New York Gold M, Siegel JE, Russell LB, Weinstein MC (1996) Cost-effectiveness in health and medicine. Oxford University Press, New York
22.
Zurück zum Zitat Badia X, Roset M, Montserrat S, Herdman M, Segura A (1999) The Spanish version of EuroQol: a description and its applications. European Quality of Life scale. Med Clin 112(Suppl 1):79–85 Badia X, Roset M, Montserrat S, Herdman M, Segura A (1999) The Spanish version of EuroQol: a description and its applications. European Quality of Life scale. Med Clin 112(Suppl 1):79–85
23.
Zurück zum Zitat Glick HA, Doshi JA, Sonnad SS, Polsky D (2014) Economic evaluation in clinical trials. Oxford University Press, New YorkCrossRef Glick HA, Doshi JA, Sonnad SS, Polsky D (2014) Economic evaluation in clinical trials. Oxford University Press, New YorkCrossRef
24.
Zurück zum Zitat Lanzeta I, Mar J, Arrospide A (2016) Cost-utility analysis of an integrated care model for multimorbid patients based on a clinical trial. Gac Sanit 30:352–358CrossRef Lanzeta I, Mar J, Arrospide A (2016) Cost-utility analysis of an integrated care model for multimorbid patients based on a clinical trial. Gac Sanit 30:352–358CrossRef
25.
Zurück zum Zitat Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res 46:399–424CrossRef Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res 46:399–424CrossRef
26.
Zurück zum Zitat Diamond A, Sekhon JS (2012) Genetic matching for estimating causal effects: a general multivariate matching method for achieving balance in observational studies. Rev Econ Stat 95:932–945CrossRef Diamond A, Sekhon JS (2012) Genetic matching for estimating causal effects: a general multivariate matching method for achieving balance in observational studies. Rev Econ Stat 95:932–945CrossRef
27.
Zurück zum Zitat Hardin J, Hilbe J (2012) Generalized linear models and extensions, 3rd edn. Taylor & Francis, Oxford Hardin J, Hilbe J (2012) Generalized linear models and extensions, 3rd edn. Taylor & Francis, Oxford
28.
Zurück zum Zitat Willan AR, Briggs AH (2006) Statistical analysis of cost-effectiveness data. Wiley, ChichesterCrossRef Willan AR, Briggs AH (2006) Statistical analysis of cost-effectiveness data. Wiley, ChichesterCrossRef
29.
Zurück zum Zitat Manca A, Hawkins N, Sculpher MJ (2005) Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 14:487–496CrossRef Manca A, Hawkins N, Sculpher MJ (2005) Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 14:487–496CrossRef
30.
Zurück zum Zitat Lim SW, Kim YJ, Kim HR (2017) Laparoscopic surgery for colorectal cancer in patients over 80 years of age: the morbidity outcomes. Ann Surg Treat Res 92:423–428CrossRef Lim SW, Kim YJ, Kim HR (2017) Laparoscopic surgery for colorectal cancer in patients over 80 years of age: the morbidity outcomes. Ann Surg Treat Res 92:423–428CrossRef
31.
Zurück zum Zitat Kazama K, Aoyama T, Hayashi T, Yamada T, Numata M, Amano S, Kamiya M, Sato T, Yoshikawa T, Shiozawa M, Oshima T, Yukawa N, Rino Y, Masuda M (2017) Evaluation of short-term outcomes of laparoscopic-assisted surgery for colorectal cancer in elderly patients aged over 75 years old: a multi-institutional study (YSURG1401). BMC Surg 17:29CrossRef Kazama K, Aoyama T, Hayashi T, Yamada T, Numata M, Amano S, Kamiya M, Sato T, Yoshikawa T, Shiozawa M, Oshima T, Yukawa N, Rino Y, Masuda M (2017) Evaluation of short-term outcomes of laparoscopic-assisted surgery for colorectal cancer in elderly patients aged over 75 years old: a multi-institutional study (YSURG1401). BMC Surg 17:29CrossRef
32.
Zurück zum Zitat Keller DS, Champagne BJ, Reynolds HL Jr, Stein SL, Delaney CP (2014) Cost-effectiveness of laparoscopy in rectal cancer. Dis Colon Rectum 57:564–569CrossRef Keller DS, Champagne BJ, Reynolds HL Jr, Stein SL, Delaney CP (2014) Cost-effectiveness of laparoscopy in rectal cancer. Dis Colon Rectum 57:564–569CrossRef
33.
Zurück zum Zitat Govaert JA, Govaert MJ, Fiocco M, van Dijk WA, Tollenaar RA, Wouters MW, Dutch Value Based Healthcare Study Group (2016) Hospital costs of colorectal cancer surgery for the oldest old: a Dutch population-based study. J Surg Oncol 114:1009–1015CrossRef Govaert JA, Govaert MJ, Fiocco M, van Dijk WA, Tollenaar RA, Wouters MW, Dutch Value Based Healthcare Study Group (2016) Hospital costs of colorectal cancer surgery for the oldest old: a Dutch population-based study. J Surg Oncol 114:1009–1015CrossRef
34.
Zurück zum Zitat Saia M, Buja A, Mantoan D, Agresta F, Baldo V (2016) Colon cancer surgery: a retrospective study based on a large administrative database. Surg Laparosc Endosc Percutan Tech 26:e126–e131 Saia M, Buja A, Mantoan D, Agresta F, Baldo V (2016) Colon cancer surgery: a retrospective study based on a large administrative database. Surg Laparosc Endosc Percutan Tech 26:e126–e131
35.
Zurück zum Zitat Alshreef A, Wailoo AJ, Brown SR, Tiernan JP, Watson AJM, Biggs K, Bradburn M, Hind D (2017) Cost-effectiveness of haemorrhoidal artery ligation versus rubber band ligation for the treatment of grade II-III haemorrhoids: analysis using evidence from the HubBLe trial. Pharmacoecon Open 1:175–184CrossRef Alshreef A, Wailoo AJ, Brown SR, Tiernan JP, Watson AJM, Biggs K, Bradburn M, Hind D (2017) Cost-effectiveness of haemorrhoidal artery ligation versus rubber band ligation for the treatment of grade II-III haemorrhoids: analysis using evidence from the HubBLe trial. Pharmacoecon Open 1:175–184CrossRef
38.
Zurück zum Zitat Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Fruth B, Meyerhardt JA, Schrag D, Greene C, O’Neil BH, Atkins JN, Berry S, Polite BN, O’Reilly EM, Goldberg RM, Hochster HS, Schilsky RL, Bertagnolli MM, El-Khoueiry AB, Watson P, Benson AB 3rd, Mulkerin DL, Mayer RJ, Blanke C (2017) Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer: a randomized clinical trial. JAMA 317:2392–2401CrossRef Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Fruth B, Meyerhardt JA, Schrag D, Greene C, O’Neil BH, Atkins JN, Berry S, Polite BN, O’Reilly EM, Goldberg RM, Hochster HS, Schilsky RL, Bertagnolli MM, El-Khoueiry AB, Watson P, Benson AB 3rd, Mulkerin DL, Mayer RJ, Blanke C (2017) Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer: a randomized clinical trial. JAMA 317:2392–2401CrossRef
39.
Zurück zum Zitat Yabroff KR, Warren JL, Schrag D, Mariotto A, Meekins A, Topor M, Brown ML (2009) Comparison of approaches for estimating incidence costs of care for colorectal cancer patients. Med Care 47:S56–63 Yabroff KR, Warren JL, Schrag D, Mariotto A, Meekins A, Topor M, Brown ML (2009) Comparison of approaches for estimating incidence costs of care for colorectal cancer patients. Med Care 47:S56–63
40.
Zurück zum Zitat Feinberg AE, Chesney TR, Acuna SA, Sammour T, Quereshy FA (2017) Oncologic outcomes following laparoscopic versus open resection of pT4 colon cancer: a systematic review and meta-analysis. Dis Colon Rectum 60:116–125CrossRef Feinberg AE, Chesney TR, Acuna SA, Sammour T, Quereshy FA (2017) Oncologic outcomes following laparoscopic versus open resection of pT4 colon cancer: a systematic review and meta-analysis. Dis Colon Rectum 60:116–125CrossRef
Metadaten
Titel
Cost-effectiveness analysis of laparoscopic versus open surgery in colon cancer
verfasst von
Javier Mar
Ane Anton-Ladislao
Oliver Ibarrondo
Arantzazu Arrospide
Santiago Lázaro
Nerea Gonzalez
Marisa Bare
Daniel Callejo
Maximino Redondo
José M. Quintana
the REDISSEC-CARESS/CCR group
Publikationsdatum
04.06.2018
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 12/2018
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-018-6250-9

Weitere Artikel der Ausgabe 12/2018

Surgical Endoscopy 12/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.